Menu ×


Necrotizing Gingivostomatitis Treatment Market Segmentation by Type {Necrotizing Ulcerative Gingivitis (NUG), Necrotizing Ulcerative Periodontitis (NUP), and Necrotizing Stomatitis (NS)}; by Treatment (Antiseptic Rinses, Antibiotic, Gingival Grafting, and Others); and by Distribution Channel (Hospital Pharmacies, Medical Store, Online, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Necrotizing Gingivostomatitis Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


  • May, 2021: Novartis to expand and strengthen its antibiotic manufacturing business in Europe.

  • July, 2019: Mylan N.V. and Upjohn, a subdivision of Pfizer Inc. collectively established a new pharmaceutical company, Vitaris Inc.

Global Necrotizing Gingivostomatitis Treatment Market Highlights over 2022 – 2030

The global necrotizing gingivostomatitis treatment market is estimated to grow at a significant CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the growing prevalence of necrotizing gingivostomatitis, especially amongst the Caucasian population. The disorder is caused by various predisposing factors, including, poor oral hygiene, smoking and drinking, unusual life stress, inadequate sleep, and others. The degrading lifestyle of the population is estimated to boost the market growth. Weakened immune system, backed by widespread infectious diseases, is another major cause of necrotizing gingivostomatitis. The increasing investment in the R&D activities in the medical field, along with rising health awareness amongst the people is estimated to boost the market growth. Moreover, the developing public healthcare infrastructure and high government expenditure for the development of new drugs is anticipated to significantly fuel the growth of the market.

necrotizing gingivostomatitis treatment market Graph

The market is segmented by type into necrotizing ulcerative gingivitis (NUG), necrotizing ulcerative periodontitis (NUP), and necrotizing stomatitis (NS), out of which, the necrotizing ulcerative gingivitis (NUG) segment is anticipated to hold the largest share in the global necrotizing gingivostomatitis treatment market over the forecast period on account of growing prevalence of the disease, backed by poor oral health. It is the most common type of necrotizing gingivostomatitis.CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Necrotizing Gingivostomatitis Treatment Market Regional Synopsis

On the basis of geographical analysis, the global necrotizing gingivostomatitis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe region is estimated to witness noteworthy growth over the forecast period on the back of large Caucasian population, and poor lifestyle of the people in developed nations. Over 50 million people in Europe suffer with chronic conditions. Similarly, the market in the North America region is anticipated to gain the largest market share throughout the forecast period, on the back of high prevalence of lifestyle diseases, caused by inactive routine, busy lifestyle, and unhealthy eating habits. According to the data by the Center of Disease Control and Prevention, over 45% of the Americans suffer from at least one chronic disease.

Necrotizing Gingivostomatitis Treatment Market Share Image

The global necrotizing gingivostomatitis treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global necrotizing gingivostomatitis treatment market includes the following segments:

By Type

  • Necrotizing Ulcerative Gingivitis (NUG)
  • Necrotizing Ulcerative Periodontitis (NUP)
  • Necrotizing Stomatitis (NS)

By Treatment

  • Antiseptic Rinses
  • Antibiotic
  • Gingival Grafting
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Medical Store
  • Online
  • Others

Growth Drivers

  • Increasing Incidences of Necrotizing Gingivostomatitis
  • Poor Lifestyle and Weak Immunity of the People


  • Circulation of Generic Drugs

Top Featured Companies Dominating the Market

  • Novartis International AG
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.,
  • Abbott Laboratories
  • Eli Lilly and Company
  • Hindustan Antibiotics Limited


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved